PharmaNet was a global contract research organization providing clinical development services, including consulting, Phase I and bio-equivalency clinical studies, and Phase II–IV clinical development programs to pharmaceutical, biotechnology, generic drug and medical device companies worldwide. JLL sold PharmaNet to inVentiv Health.